Expanding US OTC Switches Turns On Flexibility In FDA Drug Approval Process

 
• By Malcolm Spicer
  
The proposed rule was issued on 27 June and intended to broaden the range of nonprescription drugs available. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards